Use of pharmaceutical nanotechnology for the treatment of leishmaniasis
Rev. Soc. Bras. Med. Trop
;
52: e20180246, 2019. tab, graf
Artigo
em Português
| LILACS
| ID: biblio-1041535
ABSTRACT
Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. RESULTS: Our findings revealed a stable number of patents and scientific articles published over the past five years. CONCLUSIONS: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Leishmaniose
/
Nanotecnologia
/
Pesquisa Biomédica
/
Antiprotozoários
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
Idioma:
Português
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
Medicina Tropical
Ano de publicação:
2019
Tipo de documento:
Artigo
País de afiliação:
Brasil
Instituição/País de afiliação:
Universidade Federal do Piauí/BR
/
Universidade Federal do Rio de Janeiro/BR
/
Universidade Tiradentes/BR
/
Universidade de Sorocaba/BR
Similares
MEDLINE
...
LILACS
LIS